129 related articles for article (PubMed ID: 12862004)
1. Accidental germ-line modifications through somatic cell gene therapies: some ethical considerations.
Kaplan JM; Roy I
Am J Bioeth; 2001; 1(4):W13. PubMed ID: 12862004
[TBL] [Abstract][Full Text] [Related]
2. Designing babies: human research issues.
Dresser R
IRB; 2004; 26(5):1-8. PubMed ID: 15658011
[No Abstract] [Full Text] [Related]
3. Interventions in the human genome: some moral and ethical considerations.
Richter G; Bacchetta MD
J Med Philos; 1998 Jun; 23(3):303-17. PubMed ID: 9736192
[TBL] [Abstract][Full Text] [Related]
4. Transgenesis in animal systems: a view from within.
De Pomerai DI
Sci Christ Belief; 1996 Apr; 8(1):39-60. PubMed ID: 15991427
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy. An ethical profile of a new medical territory.
Fuchs M
J Gene Med; 2006 Nov; 8(11):1358-62. PubMed ID: 17068829
[TBL] [Abstract][Full Text] [Related]
6. The ethics of human gene therapy.
Walters L
Brethr Life Thought; 1986; 31(4):215-22. PubMed ID: 16715558
[No Abstract] [Full Text] [Related]
7. The ethics of gene therapy.
Chan S; Harris J
Curr Opin Mol Ther; 2006 Oct; 8(5):377-83. PubMed ID: 17078379
[TBL] [Abstract][Full Text] [Related]
8. Human gene therapy: scientific and ethical considerations.
Anderson WF
Recomb DNA Tech Bull; 1985 Jun; 8(2):55-63. PubMed ID: 3862183
[TBL] [Abstract][Full Text] [Related]
9. Assessing and communicating the risks and benefits of gene transfer clinical trials.
Kim SY
Curr Opin Mol Ther; 2006 Oct; 8(5):384-9. PubMed ID: 17078380
[TBL] [Abstract][Full Text] [Related]
10. Ethical considerations of fetal therapy.
Noble R; Rodeck CH
Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):219-31. PubMed ID: 17892972
[TBL] [Abstract][Full Text] [Related]
11. The hazards of human developmental gene modification.
Newman SA
Genewatch; 2000 Jul; 13(3):10-2. PubMed ID: 12814104
[No Abstract] [Full Text] [Related]
12. Ethics of genetic modifications of behavior.
Shamoo AE; Cole J
Account Res; 2004; 11(3-4):201-14. PubMed ID: 15812966
[No Abstract] [Full Text] [Related]
13. Ethical consideration.
Fuchs M
Methods Mol Biol; 2011; 737():407-24. PubMed ID: 21590407
[TBL] [Abstract][Full Text] [Related]
14. Catch-22: this gene therapy could work so well it'll have to be banned.
Westphal SP
New Sci; 2002 Mar; 173(2336):7. PubMed ID: 12374172
[No Abstract] [Full Text] [Related]
15. The risks of germline gene transfer.
High KA
Hastings Cent Rep; 2003; 33(2):3. PubMed ID: 12760106
[No Abstract] [Full Text] [Related]
16. Male germ-line cells are at risk following direct-injection retroviral-mediated gene transfer in utero.
Porada CD; Park PJ; Tellez J; Ozturk F; Glimp HA; Almeida-Porada G; Zanjani ED
Mol Ther; 2005 Oct; 12(4):754-62. PubMed ID: 16084775
[TBL] [Abstract][Full Text] [Related]
17. On the scientific and ethical issues of fetal somatic gene therapy.
Coutelle C; Rodeck C
Gene Ther; 2002 Jun; 9(11):670-3. PubMed ID: 12032684
[TBL] [Abstract][Full Text] [Related]
18. Risks, benefits and ethical, legal, and societal considerations for translation of prenatal gene therapy to human application.
Coutelle C; Ashcroft R
Methods Mol Biol; 2012; 891():371-87. PubMed ID: 22648781
[TBL] [Abstract][Full Text] [Related]
19. [Gene therapy and ethics].
Müller H; Rehmann-Sutter C
Schweiz Med Wochenschr; 1995 Jan; 125(1-2):34-41. PubMed ID: 7839108
[TBL] [Abstract][Full Text] [Related]
20. Commentary: maintaining the somatic/germ-line distinction: some ethical drawbacks.
Moseley R
J Med Philos; 1991 Dec; 16(6):641-7. PubMed ID: 1787392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
